Development of a VEGFR3 imaging agent by PET for predictive diagnosis of lymph node metastasis.
| Project/Area Number |
21791168
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
FURUMOTO Shozo Tohoku University, 大学院・医学系研究科, 准教授 (00375198)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Keywords | 放射性医薬品 / 造影剤 / PET / VEGFR-3 / リンパ管新生 / リンパ節転移 / イメージング |
|---|
| Research Abstract |
The purpose of this study was to develop a new radiolabeled imaging probe to visualize a VEGFR3 receptor, which is a key molecule in the early process of lymph node metastasis. Thus, imaging of VEGFR3 would be applicable to early diagnosis of lymph node metastasis. In this study, 11C-labeled VEGFR3 and its precursor for radiolabeling by methylation was successfully synthesized. Small animal PET imaging with the tracer showed a radioactivity uptake in tumor tissue in an AH109A tumor bearing rat.
|
Report
(3 results)
Research Products
(3 results)
